Across TCGA pan-cancer cohorts, RNU6-173P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU6-173P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU6-173P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-173P is over-expressed in tumor.

KIRC, HNSC, and LUSC are the cancer types where RNU6-173P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-173P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.063	.005	8	view →
HNSC	All	All	+0.115	.011	5	view →
LUSC	All	All	+0.176	.002	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-173P RNA expression & survival · all RNU6-173P data types